J. Scott Garland

Director

Director at Enliven Therapeutics, Inc., filing insider transactions on 2026-10-01.

Total Purchases

—

0 transactions

Total Sales

$607K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-10-01

Last: 2026-10-01

Companies

Enliven Therapeutics, Inc.

Other Reporting Insiders at Enliven Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-01	ELVN	Sale	13.0K	$46.67	$607K	0	SEC ↗

J. Scott Garland (Enliven Therapeutics, Inc.) Insider Trades | Tormere